Evidence map›Paper›PMID 34996524›Full record

ReviewEye and vision (London, England)2022

Application of artificial intelligence in cataract management: current and future directions.

Laura Gutierrez, Jane Sujuan Lim, Li Lian Foo, Wei Yan Ng, Michelle Yip, Gilbert Yong San Lim, Melissa Hsing Yi Wong, Allan Fong, Mohamad Rosman, Jodhbir Singth Mehta and 3 more

Erratum issuedOpen access · diamondAbstract readReview
In one paragraph

Review in Eye and vision (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Artificial intelligence in ophthalmology: opportunities, challenges, and ethical considerations.Medical hypothesis, discovery & innovation ophthalmology journal · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Applications of Artificial Intelligence in Cataract Surgery: A Review.Clinical ophthalmology (Auckland, N.Z.) · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Laura Gutierrez *Singapore Eye Research Institute, Singapore, Singapore.
Jane Sujuan Lim *Singapore Eye Research Institute, Singapore, Singapore.
Li Lian FooSingapore Eye Research Institute, Singapore, Singapore.
Wei Yan NgSingapore Eye Research Institute, Singapore, Singapore.
Michelle YipSingapore Eye Research Institute, Singapore, Singapore.
Gilbert Yong San LimSingapore Eye Research Institute, Singapore, Singapore.
Melissa Hsing Yi WongSingapore National Eye Center, 11 Third Hospital Avenue, Singapore, 168751, Singapore.
Allan FongSingapore National Eye Center, 11 Third Hospital Avenue, Singapore, 168751, Singapore.
Mohamad RosmanSingapore Eye Research Institute, Singapore, Singapore.
Jodhbir Singth MehtaSingapore Eye Research Institute, Singapore, Singapore.
Haotian LinZhongshan Ophthalmic Center, Sun Yet Sen University, Guangzhou, China.
Darren Shu Jeng TingAcademic Ophthalmology, School of Medicine, University of Nottingham, Nottingham, UK.
Daniel Shu Wei TingSingapore Eye Research Institute, Singapore, Singapore. daniel.ting45@gmail.com.
Singapore Eye Research Institute · SGSingapore National Eye Center · SGUniversity of Nottingham · GBZhongshan Ophthalmic Center, Sun Yat-sen University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of artificial intelligence (AI) has brought breakthroughs in many areas of medicine. In ophthalmology, AI has delivered robust results in the screening and detection of diabetic retinopathy, age-related macular degeneration, glaucoma, and retinopathy of prematurity. Cataract management is another field that can benefit from greater AI application. Cataract  is the leading cause of reversible visual impairment with a rising global clinical burden. Improved diagnosis, monitoring, and surgical management are necessary to address this challenge. In addition, patients in large developing countries often suffer from limited access to tertiary care, a problem further exacerbated by the ongoing COVID-19 pandemic. AI on the other hand, can help transform cataract management by improving automation, efficacy and overcoming geographical barriers. First, AI can be applied as a telediagnostic platform to screen and diagnose patients with cataract using slit-lamp and fundus photographs. This utilizes a deep-learning, convolutional neural network (CNN) to detect and classify referable cataracts appropriately. Second, some of the latest intraocular lens formulas have used AI to enhance prediction accuracy, achieving superior postoperative refractive results compared to traditional formulas. Third, AI can be used to augment cataract surgical skill training by identifying different phases of cataract surgery on video and to optimize operating theater workflows by accurately predicting the duration of surgical procedures. Fourth, some AI CNN models are able to effectively predict the progression of posterior capsule opacification and eventual need for YAG laser capsulotomy. These advances in AI could transform cataract management and enable delivery of efficient ophthalmic services. The key challenges include ethical management of data, ensuring data security and privacy, demonstrating clinically acceptable performance, improving the generalizability of AI models across heterogeneous populations, and improving the trust of end-users.

Indexed as

Artificial intelligenceBiometryCataractCataract screeningCataract surgeryIOL calculationsMachine learningTelemedicine

Identifiers

PMID34996524
PMCPMC8739505
OpenAlexW4206341585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.